Matches in Nanopublications for { ?s ?p "[FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 16 of
16
with 100 items per page.
- NP586556.RAqtTaC32ztDlWoidz8LeGezp1QfoAtTe0T_J2cJhonuU130_assertion description "[FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586556.RAqtTaC32ztDlWoidz8LeGezp1QfoAtTe0T_J2cJhonuU130_provenance.
- NP390817.RAakRBzym1P7kxSE8u1xTexmYwflWItedIWili2giz3i4130_assertion description "[FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390817.RAakRBzym1P7kxSE8u1xTexmYwflWItedIWili2giz3i4130_provenance.
- NP555131.RAmglsuJhbEzVrdn8CkQJzj7LuQcxZADB8bB3QV4VDBvU130_assertion description "[FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP555131.RAmglsuJhbEzVrdn8CkQJzj7LuQcxZADB8bB3QV4VDBvU130_provenance.
- NP721260.RAePWi5HwlQS7S9GTffD8pWIxrJZaM5E6WVZGkad4AwbE130_assertion description "[FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP721260.RAePWi5HwlQS7S9GTffD8pWIxrJZaM5E6WVZGkad4AwbE130_provenance.
- assertion description "[FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP330680.RAVFuRSKMGqMgCfI1EjfSkpv0k1scIx32sspv2Wf2qpbA130_assertion description "[FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP330680.RAVFuRSKMGqMgCfI1EjfSkpv0k1scIx32sspv2Wf2qpbA130_provenance.
- NP548722.RAXzsDarYDu9scjY6YTcJweIlvKrgX-lkTqOvxlYB-dDA130_assertion description "[FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548722.RAXzsDarYDu9scjY6YTcJweIlvKrgX-lkTqOvxlYB-dDA130_provenance.
- NP396805.RA-MjB5jGqs9f4Hf0kjoTGd9XyTTZJMlvi0X5PfEL1mx4130_assertion description "[FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP396805.RA-MjB5jGqs9f4Hf0kjoTGd9XyTTZJMlvi0X5PfEL1mx4130_provenance.
- NP396848.RA8_vAMF76mQ7Mrw8FrrEWOC82kA4FkGu58IZTUjfbDAg130_assertion description "[FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP396848.RA8_vAMF76mQ7Mrw8FrrEWOC82kA4FkGu58IZTUjfbDAg130_provenance.
- NP331221.RAO5lTpHmzoRQ-6yCdpZqZCje-nA20PMAsX03hnUMf3bw130_assertion description "[FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331221.RAO5lTpHmzoRQ-6yCdpZqZCje-nA20PMAsX03hnUMf3bw130_provenance.
- NP548724.RAFYzofbqvLo9RryrY67LQNKjHSZ_WGlWpYyiLOy6n0BQ130_assertion description "[FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548724.RAFYzofbqvLo9RryrY67LQNKjHSZ_WGlWpYyiLOy6n0BQ130_provenance.
- NP548723.RA3HeeK9kr2VVlnFLKUMRk9XLY4LGP1OCUr8oq4SluV4E130_assertion description "[FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548723.RA3HeeK9kr2VVlnFLKUMRk9XLY4LGP1OCUr8oq4SluV4E130_provenance.
- NP548725.RA2LYnowyrksnpJGF7tKANlgDx2hNzGnirwsq5iewjIIM130_assertion description "[FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548725.RA2LYnowyrksnpJGF7tKANlgDx2hNzGnirwsq5iewjIIM130_provenance.